Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Rotow JK"'
Autor:
Blakely CM; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Urisman A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Pathology, University of California, San Francisco, San Francisco, CA., Gubens MA; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Mulvey CK; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Allen GM; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Shiboski SC; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Chakrabarti T; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Kerr DL; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Aredo JV; Department of Medicine, University of California, San Francisco, San Francisco, CA., Bacaltos B; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Gee M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Tan L; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Jones KD; Department of Pathology, University of California, San Francisco, San Francisco, CA., Devine WP; Department of Pathology, University of California, San Francisco, San Francisco, CA.; Institute for Human Genetics, University of California, San Francisco, San Francisco, CA., Doebele RC; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Aisner DL; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO., Patil T; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Schenk EL; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Bivona TG; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Chan Zuckerberg Biohub, San Francisco, CA., Riess JW; Department of Medicine, University of California Davis, Sacramento, CA., Coleman M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA., Kratz JR; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA., Jablons DM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 10; Vol. 42 (26), pp. 3105-3114. Date of Electronic Publication: 2024 Jul 19.
Autor:
Haderk F; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Chou YT; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Cech L; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA., Fernández-Méndez C; Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científícas (CSIC) y Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Yu J; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA., Olivas V; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Meraz IM; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Barbosa Rabago D; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Kerr DL; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Gomez C; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Allegakoen DV; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Guan J; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA., Shah KN; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA., Herrington KA; Center for Advanced Light Microscopy, University of California, San Francisco, San Francisco, CA, USA., Gbenedio OM; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA., Nanjo S; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan., Majidi M; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tamaki W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Pourmoghadam YK; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McCoach CE; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Riess JW; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Gutkind JS; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Tang TT; Vivace Therapeutics, Inc., 1500 Fashion Island Blvd., Suite 102, San Mateo, CA, USA., Post L; Vivace Therapeutics, Inc., 1500 Fashion Island Blvd., Suite 102, San Mateo, CA, USA., Huang B; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Santisteban P; Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científícas (CSIC) y Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Goodarzi H; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA., Bandyopadhyay S; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA., Kuo CJ; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Roose JP; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA., Wu W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Blakely CM; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Roth JA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bivona TG; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 May 03; Vol. 15 (1), pp. 3741. Date of Electronic Publication: 2024 May 03.
Autor:
Sharp JA; 1Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Jones D; 2Department of Pathology, The Ohio State University, Columbus, OH., Rotow JK; 3Dana-Farber Cancer Institute, Boston, MA., Fidias PM; 4Massachusetts General Cancer Center at Exeter Hospital, Exeter, NH., Bertino E; 1Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; 5Columbus Oncology and Hematology Associates, Columbus, OH., Owen DH; 1Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Mar 13; Vol. 22 (3). Date of Electronic Publication: 2024 Mar 13.
Autor:
Rotow JK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lee JK; Department of Clinical Development, Foundation Medicine, Inc., Boston, Massachusetts., Madison RW; Department of Clinical Development, Foundation Medicine, Inc., Boston, Massachusetts., Oxnard GR; Department of Clinical Development, Foundation Medicine, Inc., Boston, Massachusetts., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schrock AB; Department of Clinical Development, Foundation Medicine, Inc., Boston, Massachusetts. Electronic address: aschrock@foundationmedicine.com.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Feb; Vol. 19 (2), pp. 227-239. Date of Electronic Publication: 2023 Oct 06.
Autor:
Caswell DR; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. deborah.caswell@crick.ac.uk., Gui P; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Mayekar MK; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Law EK; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bailey C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Boumelha J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Kerr DL; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Blakely CM; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Manabe T; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Martinez-Ruiz C; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Bakker B; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., De Dios Palomino Villcas J; Core Research Laboratory, ISPRO, Florence, Italy., I Vokes N; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dietzen M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Gini B; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Tamaki W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Allegakoen P; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Wu W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Humpton TJ; p53 and Metabolism Laboratory, The Francis Crick Institute, London, UK.; CRUK Beatson Institute, Glasgow, UK.; Glasgow Caledonian University, Glasgow, UK., Hill W; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Tomaschko M; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Lu WT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Haderk F; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Nagano A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Gimeno-Valiente F; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., de Carné Trécesson S; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Vendramin R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Barbè V; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Mugabo M; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Weeden CE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., McCoach CE; Genentech Inc, South San Francisco, CA, USA., Almeida B; The Roger Williams Institute of Hepatology, Foundation for Liver Research, London, UK.; Faculty of Life Sciences & Medicine, King's College London, London, UK., Green M; Experimental Histopathology, The Francis Crick Institute, London, UK., Gomez C; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Nanjo S; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Barbosa D; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Moore C; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Przewrocka J; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Black JRM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Suarez-Bonnet A; Experimental Histopathology, The Francis Crick Institute, London, UK.; Department of Pathobiology & Population Sciences, The Royal Veterinary College, London, UK., Priestnall SL; Experimental Histopathology, The Francis Crick Institute, London, UK.; Department of Pathobiology & Population Sciences, The Royal Veterinary College, London, UK., Zverev C; Biological Research Facility, The Francis Crick Institute, London, UK., Lighterness S; Biological Research Facility, The Francis Crick Institute, London, UK., Cormack J; Biological Research Facility, The Francis Crick Institute, London, UK., Olivas V; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Cech L; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Andrews T; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Rule B; Cursorless, London, UK., Jiao Y; Novogene Europe, Cambridge, UK., Zhang X; Novogene Europe, Cambridge, UK., Ashford P; Institute of Structural and Molecular Biology, University College London, London, UK., Durfee C; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA., Venkatesan S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Temiz NA; Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Tan L; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Larson LK; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA., Argyris PP; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.; School of Dentistry, University of Minnesota, Minneapolis, MN, USA.; College of Dentistry, Ohio State University, Columbus, OH, USA., Brown WL; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA., Yu EA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Sutter Health Palo Alto Medical Foundation, Department of Pulmonary and Critical Care, Mountain View, CA, USA., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Guha U; Thoracic and GI Malignancies Branch, NCI, NIH, Bethesda, MD, USA.; NextCure Inc., Beltsville, MD, USA., Roper N; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Yu J; Biomedical Sciences Program, University of California, San Francisco, San Francisco, CA, USA., Vogel RI; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA., Thomas NJ; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Marra A; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology IRCCS, Milan, Italy., Selenica P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Yu H; Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell College of Medicine, New York City, NY, USA., Bakhoum SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Chew SK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Reis-Filho JS; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK., Vousden KH; p53 and Metabolism Laboratory, The Francis Crick Institute, London, UK., McGranahan N; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Harris RS; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.; Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX, USA., Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Bivona TG; Departments of Medicine and Cellular and Molecular Pharmacology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Chan Zuckerberg Biohub, San Francisco, CA, USA. trever.bivona@ucsf.edu., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.
Publikováno v:
Nature genetics [Nat Genet] 2024 Jan; Vol. 56 (1), pp. 60-73. Date of Electronic Publication: 2023 Dec 04.
Autor:
Makarem M; Dana-Farber Cancer Institute, Lowe Center for Thoracic Oncology, Boston, Massachusetts., Rotow JK; Dana-Farber Cancer Institute, Lowe Center for Thoracic Oncology, Boston, Massachusetts. Electronic address: julia_rotow@dfci.harvard.edu.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Dec; Vol. 18 (12), pp. 1615-1617.
Autor:
Banla LI; Harvard Radiation Oncology Program, Boston, Massachusetts., Tzeng A; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Baillieul JP; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Kandekhar MJ; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Fitzgerald KJ; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., LoPiccolo J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Poitras HA; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Soto DE; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Singer L; Department of Radiation Oncology, University of California San Francisco, San Francisco, California., Willers H; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Kozono DE; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Janne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mak RH; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Piotrowska Z; Department of Medicine, Division of Hematology/ Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Keane FK; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Kann BH; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2023 Aug 17; Vol. 4 (10), pp. 100559. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).
Autor:
Ji J; City of Hope Comprehensive Cancer Center, Duarte, California.; UC Davis Comprehensive Cancer Center, Sacramento, California., Aredo JV; Stanford Cancer Institute, Stanford, California., Piper-Vallillo A; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Huppert L; UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California., Rotow JK; Dana-Farber Cancer Institute, Boston, Massachusetts., Husain H; UCSD Moores Comprehensive Cancer Center, La Jolla, San Diego, California., Stewart S; UC Davis Comprehensive Cancer Center, Sacramento, California., Cobb R; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Wakelee HA; Stanford Cancer Institute, Stanford, California., Blakely CM; UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California., Wong ML; UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California., Gubens MA; UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California., Madani MH; UC Davis Comprehensive Cancer Center, Sacramento, California., Digumarthy SR; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., McCoach C; UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California., Piotrowska Z; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Neal JW; Stanford Cancer Institute, Stanford, California., Riess JW; UC Davis Comprehensive Cancer Center, Sacramento, California.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2023 Jan 10; Vol. 4 (3), pp. 100459. Date of Electronic Publication: 2023 Jan 10 (Print Publication: 2023).
Autor:
Piper-Vallillo AJ; Massachusetts General Hospital, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Rotow JK; Harvard Medical School, Boston, Massachusetts.; Dana Farber Cancer Institute, Boston, Massachusetts., Aredo JV; Stanford University School of Medicine, Stanford, California., Shaverdashvili K; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania., Luo J; Harvard Medical School, Boston, Massachusetts.; Dana Farber Cancer Institute, Boston, Massachusetts.; Memorial Sloan Kettering Cancer Center, New York, New York., Carlisle JW; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Husain H; University of California San Diego Medical Center, La Jolla, California., Muzikansky A; Massachusetts General Hospital, Boston, Massachusetts., Heist RS; Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Rangachari D; Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Ramalingam SS; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Wakelee HA; Stanford University School of Medicine, Stanford, California., Yu HA; Memorial Sloan Kettering Cancer Center, New York, New York., Sequist LV; Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Bauml JM; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania., Neal JW; Stanford University School of Medicine, Stanford, California., Piotrowska Z; Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2022 Apr 21; Vol. 3 (6), pp. 100328. Date of Electronic Publication: 2022 Apr 21 (Print Publication: 2022).
Autor:
Lee Y; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Clark EW; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Milan MSD; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Champagne C; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Michael KS; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Barbie DA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Cheng ML; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Kehl KL; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Marcoux JP; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Rabin MS; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Sands JM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Oxnard GR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2020 Sep 21; Vol. 4. Date of Electronic Publication: 2020 Sep 21 (Print Publication: 2020).